{"id":"W4361238647","doi":"10.1093/ofid/ofad150","title":"Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2)","year":2023,"lang":"en","type":"article","venue":"Open Forum Infectious Diseases","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Impact","funders":"UZH Foundation; Promedica Stiftung; Moderna; OPEC Fund for International Development; ViiV Healthcare; Universität Basel; National Institutes of Health; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Gilead Sciences; Sanofi; Universität Zürich; Pfizer; National Science Foundation","keywords":"Medicine; Immunosuppression; Confidence interval; Antibody response; Vaccination; Randomized controlled trial; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Antibody; Immunology; Virology; Internal medicine; Outbreak","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002442821,0.0008383812,0.001898528,0.000169471,0.0002354245,0.0007465193,0.0004516336,0.001355762,0.003575886],"category_scores_gemma":[0.001914958,0.000302687,0.002133517,0.00019341,0.0006626425,0.0006237018,0.0002909462,0.002386115,0.0005234458],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006516417,"about_ca_system_score_gemma":0.0009660044,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009652582,"about_ca_topic_score_gemma":0.001431647,"domain_scores_codex":[0.9989381,0.0005854395,0.00004851055,0.0001579596,0.00008760735,0.0001823851],"domain_scores_gemma":[0.9988208,0.0003336121,0.0003101412,0.0001430698,0.00008146836,0.0003108652],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.975687,0.003595763,0.001945059,0.0001884443,0.0009154674,0.00003197106,0.0000307239,0.0002164175,0.004524927,0.00008026478,0.0006829041,0.01210099],"study_design_scores_gemma":[0.7899896,0.1893048,0.01470035,0.00006669631,0.001289303,0.00007049084,0.00002345131,0.0006164613,0.002579999,0.0001898621,0.001147768,0.00002125974],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950027,0.001438186,0.0003404202,0.000449442,0.0002505186,0.0006327622,0.0005709186,0.00004207885,0.001272961],"genre_scores_gemma":[0.9953061,0.0004894435,0.000586469,0.000563533,0.0002462807,0.0005855263,0.0009628876,0.00001422292,0.001245554],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003575886,"threshold_uncertainty_score":0.01291901,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02189442284047636,"score_gpt":0.3494455680000531,"score_spread":0.3275511451595767,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}